In some embodiments, the short, second dsRNA binds PKR and inhibits the dimerization and/or activation of PKR. In another aspect, the invention provides a method for inhibiting the expression of a target nucleic acid in an animal (e.g., an invertebrate or a vertebrate such as a mammal or human).